EMADINE EYE DROPS

Indications

• Hypertension
• Heart failure
• Peripheral vascular disease
• Angina pectoris

Dosage

Children: Refer to specialized pediatric dosing guidelines, as individual needs may vary significantly.

Adults: Refer to specific guidelines for dosing based on clinical condition; individualized dosing is often required.

Mechanism of action

Difumarate acts as a vasodilator by increasing the levels of cyclic guanosine monophosphate (cGMP) in vascular smooth muscle cells. This increase leads to relaxation of the smooth muscle, resulting in the dilation of blood vessels. The compound may also enhance the availability of nitric oxide, a potent vasodilator, further contributing to its effects on vascular tone.

Pharmacodynamics

The pharmacodynamic effects of difumarate include a decrease in systemic vascular resistance and an increase in blood flow to various tissues. This can result in improved oxygen delivery and reduced workload on the heart, making it beneficial in conditions such as heart failure and hypertension. Additionally, the drug may exhibit some anti-platelet activity, which can be advantageous in preventing thrombotic events.

Pharmacokinetics

Difumarate is absorbed relatively quickly following oral administration, with peak plasma concentrations typically occurring within a few hours. It undergoes hepatic metabolism, and its metabolites are primarily excreted via the kidneys. The drug has a variable half-life, which may be influenced by factors such as liver function and concurrent medications. Its pharmacokinetic profile necessitates careful monitoring, particularly in patients with renal or hepatic impairment.

Pregnancy

There is limited information on the safety of difumarate during pregnancy. Caution is advised, and it is recommended to consult a healthcare professional before use.

Breast-feeding

The excretion of difumarate in human milk is unknown. Caution is advised when administering to nursing mothers.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Indications

• Allergic conjunctivitis
• Seasonal allergic rhinitis

Dosage

Children: For children, refer to the BNF for Children for specific dosing recommendations, as pediatric dosing may vary based on age and clinical condition.

Adults: For adults, the typical dose is one drop in the affected eye(s) up to four times daily, as directed by a healthcare provider.

Mechanism of action

Emadastine exerts its effects by selectively antagonizing the H1 histamine receptor, which prevents histamine from binding to these receptors and thus reduces the symptoms associated with allergic reactions, such as itching and redness in the eyes.

Pharmacodynamics

As a selective H1 receptor antagonist, emadastine reduces the effects of histamine, which is responsible for various allergic symptoms. Its action leads to a decrease in vascular permeability, preventing fluid leakage and subsequent edema in the conjunctival tissue. The onset of action is typically rapid, providing relief shortly after administration.

Pharmacokinetics

Emadastine, when administered topically as an eye drop, has limited systemic absorption, which minimizes potential side effects. It is rapidly distributed in the ocular tissues, with peak concentrations achieved within minutes of administration. The elimination half-life is relatively short, necessitating multiple doses throughout the day to maintain therapeutic levels.

Contra-indications

• Hypersensitivity to emadastine or any of its components
• Active ocular infections

Adverse effects

• Burning sensation in the eyes
• Dryness of the eyes
• Itching of the eyes
• Redness of the eyes
• Allergic reactions

Precautions

• Use with caution in patients with a history of hypersensitivity reactions
• Not recommended for use in patients with severe dry eye syndrome
• Monitor for signs of ocular irritation

Pregnancy

There are no adequate and well-controlled studies in pregnant women. Use only if clearly needed and the benefits outweigh the risks.

Breast-feeding

It is not known if emadastine is excreted in human milk. Caution should be exercised when administering to a nursing woman.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

• Emadastine 0.05% eye drops